The FDA is now requiring safety labeling changes for prescription cough and cold medicines containing codeine or hydrocodone to limit the use of these products to adults 18 years and older because the risks of these medicines outweigh their benefits in children younger than 18. Codeine and hydrocodone are available in combination with other medicines,...
A cohort study of 140,352 diabetics showed that sodium-glucose cotransporter 2 (SGLT2 inhibitors) diabetes drugs were associated with approximately twice the risk of diabetic ketoacidosis as were dipeptidyl peptidase-4 (DPP4 inhibitors) diabetes drugs according to a recent letter to the New England Journal of Medicine. SGLT2 inhibitors are a class of prescription medicines that are...
On May 31, 2017, Ohio Attorney General Mike DeWine filed a lawsuit against five leading prescription opioid manufacturers and their related companies, charging that the drug companies engaged in fraudulent marketing about the risks and benefits of prescription opioids, which misled patients and fueled Ohio’s opioid epidemic. Specifically, the lawsuit (State of Ohio ex rel....
Today, the FDA issued a drug safety communication that it has approved previously announced label changes regarding the use of general anesthetic and sedation medicines in children younger than 3 years. These changes include: A new Warning stating that exposure to these medicines for lengthy periods of time or over multiple surgeries or procedures may...
Last week, a motion was filed requesting multidistrict litigation (MDL) for lawsuits of individuals with kidney damage or diabetic ketoacidosis from taking the prescription, Invokana. Invokana (canagliflozin) is an oral prescription used to help lower blood glucose in patients with type 2 diabetes. Multidistrict litigation is a special procedure in which federal civil (noncriminal) cases from around the...
On August 1, 2016, U.S. District Court Judge Eldon E. Fallon issued Case Management Order No. 5, which describes the bellwether cases to go to trial in the Xarelto® (rivaroxaban) multidistrict litigation. This litigation involves hundreds of lawsuits from across the country alleging that individuals taking Xarelto® suffered severe or fatal bleeding or other injuries....
On July 22, a motion was filed requesting a new multidistrict litigation (MDL) for lawsuits alleging that Sanofi SA’s chemotherapy drug, Taxotere, can cause permanent hair loss, particularly in those being treated for breast cancer. Multidistrict litigation is a special procedure in which federal civil (noncriminal) cases from around the country are transferred to one...
If you are one of the millions of Americans taking heartburn drugs, such as Prevacid, Prilosec, Nexium, Protonix, Aciphex and others, recent studies suggest you could be at an increased risk of kidney disease, kidney disease progression, and end-stage renal disease. Heartburn drugs are called proton pump inhibitors or “PPIs.” They help people who suffer from regular heartburn,...
